Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion evidence source_evidence_literature NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion SIO_000772 23798432 NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion wasDerivedFrom befree-20140225 NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_assertion wasGeneratedBy ECO_0000203 NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP458597.RAmLVRDKsfYFCymkF3L7hPQ1tLOx-GG2n2dUYWUZNPKSo130_provenance.